Dr. Claudio Denoya Appointed to United States Pharmacopoeia Panel

Boulder, Colorado, February 8, 2016 (Newswire.com) - Dr. Claudio Denoya, Senior Scientist at Particle Measuring Systems (PMS), was recently appointed to the Modern Microbiology Methods Expert Panel of the United States Pharmacopoeia (USP) in an advisory role. The panel will make recommendations for a new USP Chapter to support changes in knowledge and technology in the microbiology industry. Dr. Denoya has a strong background in the pharmaceutical sciences microbiology area, and provides the panel with his depth of knowledge in understanding novel, alternative and rapid microbiological methods.

“Particle Measuring Systems invests in industry experts to help our customers be more effective and comply with all relevant regulations. As a leader in the industry it is important that we participate on panels such as this to help move the industry forward”, said John Mitchell, President of Particle Measuring Systems.

Prior to joining PMS, Dr. Denoya was a Senior Director of the BioPharm R&D Group at Pall Corporation (New York) working on the development of new technologies. He also spent more than 23 years at Pfizer Global R&D. Claudio has received numerous distinctions such as, six Pfizer Global R&D distinguished awards, the United States National Hispanic Corporate Organization award, and the University of Buenos Aires, Faculty of Biochemistry award. He has over 80 patents and publications and more than 250 presentations in the fields of Microbiology, Biochemistry, Molecular Genetics and Pharmaceutical Sciences.

About Particle Measuring Systems

A global technology leader in the environmental monitoring industry, PMS, a Spectris company, is the inventor of laser particle counting and the largest particle counter manufacturer in the world. Regardless of industry or monitoring requirements, PMS helps manufacturers measure what matters.

For more information on PMS, visit pmeasuring.com.

###​